Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...
MM&M4h
Lift tickets: 6 drug launches set for a hefty sales ramp
These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...
PD: 72-year-old woman killed in possible drive-by shooting in Phoenix
Police are asking the community for help after the deadly shooting of a 72-year-old woman in Phoenix Sunday evening. Officers ...
What Analysts Think of Eli Lilly Stock Ahead of Earnings
Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the ...
SA Asks: What's the most attractive weight-loss stock right now?
While Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) still rule the weight-loss drug market with their respective GLP-1 medications, competition could soon be heating up as rival products near ...
Vice President JD Vance visits East Palestine on derailment anniversary
On July 24, 2024, pro-life activist Bevelyn Williams was sentenced by U.S. District Judge Jennifer L. Rochon to 41 months in ...
Hosted on MSN7h
Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock?
Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...
Drinking. Gambling. Online shopping. Patients say obesity drugs curb any number of ‘gluttonous impulses.’
GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...
Why Eli Lilly and Company (LLY) Is the Best Cancer Stock to Buy According to Hedge Funds
Eli Lilly & Co. (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. Its products span oncology, ...